South Korea Diabetes Devices Market

South Korea Diabetes Devices Market Overview:

The South Korea diabetes devices market size reached USD 366.04 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 775.52 Million by 2033, exhibiting a growth rate (CAGR) of 8.10% during 2025-2033. Rising diabetes prevalence, increased awareness about early diagnosis and management, government initiatives for healthcare improvement, advancements in glucose monitoring technologies, and the growing adoption of telemedicine and mobile health solutions are the factors propelling the growth of the market.

South Korea Diabetes Devices Market Trends:

Increase in Digital Integration for Diabetes Management

The integration of digital health technologies with chronic disease management applications improves individualized treatment for diabetic patients. Patients may monitor key health data such as blood glucose levels, food, exercise, and medicine in real-time by connecting their insulin pens to mobile apps. This integration increases treatment adherence by enabling continuous tracking and insulin management via linked devices. Localized apps improve accessibility by allowing users to interact with the technology in their preferred language. These improvements make diabetes treatment more effective and personalized, resulting in improved patient outcomes through data-driven insights and streamlined daily management. For example, in August 2024, Health2Sync and Sanofi expanded their partnership by providing the SoloSmart solution for individualized diabetes treatment in South Korea. SoloSmart's interface with Health2Sync's "SugarGenie" app allows patients to monitor blood glucose, nutrition, exercise, and medicines. This collaboration is the first time SoloSmart has been integrated with a chronic illness management app in South Korea, improving daily diabetes management and user experience. The software, now available in Korean, provides seamless tracking and insulin control using the SoloSmart connected pen cap.

Growing Innovation in Continuous Glucose Monitoring

The introduction of locally made continuous glucose monitoring (CGM) devices is transforming diabetes care. The most recent innovation is the smallest and lightest CGM available, with up to 15 days of use and enhanced calibration for precise readings. This breakthrough improves the convenience and precision of diabetes control, making it more convenient for patients. With formal certification and mass manufacturing underway, this device is poised to expand into overseas markets, including Europe, provided it achieves CE approval. This trend toward domestic technology adds to the burgeoning ecosystem of innovative medical devices that aim to enhance patient outcomes and simplify chronic illness care. For instance, in June 2023, i-SENS developed CareSens Air, South Korea's first domestically manufactured continuous glucose monitoring (CGM) device, which has officially been certified by the Ministry of Food and Drug Safety. The device is the smallest and lightest CGM available, with a 15-day use length and enhanced calibration for precise readings. i-SENS accelerated its manufacturing in Q3 2024. As the fourth CGM certified in South Korea, the device may access international markets, including Europe after obtaining CE authorization.

South Korea Diabetes Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on type and distribution channel.

Type Insights:

• Management Devices
• Monitoring Devices

The report has provided a detailed breakup and analysis of the market based on the type. This includes management devices and monitoring devices.

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, diabetes clinics/centers, online pharmacies, and others.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

South Korea Diabetes Devices Market News:

• In February 2025, Health2Sync's SugarGenie app strengthened its presence in South Korea's diabetes treatment market. Healthcare specialists praised the software for its ability to improve diabetes monitoring and control. Its use in hospitals and government health programs enhanced patient care. SugarGenie got active in over 100 healthcare facilities in December 2024, assisting with the management of chronic illnesses such as diabetes, hypertension, and obesity, as well as harmonizing with national health programs for more customized and data-driven treatment.
• In May 2024, Kakao Healthcare signed a memorandum of understanding with Rumah Sakit Universitas Indonesia (RSUI) to launch its AI-powered diabetes management software. Pasta, a smartphone app, uses artificial intelligence to monitor blood sugar levels. It works with a continuous glucose monitor to produce near-real-time glucose measurements. The app also collects data on nutrition, exercise, and sleep, and uses this information, together with blood sugar levels, to provide automatic lifestyle suggestions.

South Korea Diabetes Devices Market Report Coverage:

Key Questions Answered in This Report:

• How has the South Korea diabetes devices market performed so far and how will it perform in the coming years?
• What is the breakup of the South Korea diabetes devices market on the basis of type?
• What is the breakup of the South Korea diabetes devices market on the basis of distribution channel?
• What are the various stages in the value chain of the South Korea diabetes devices market? 
• What are the key driving factors and challenges in the South Korea diabetes devices market?
• What is the structure of the South Korea diabetes devices market and who are the key players?
• What is the degree of competition in the South Korea diabetes devices market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the South Korea diabetes devices market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the South Korea diabetes devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the South Korea diabetes devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.